Growing evidence suggests that NLRP3 inflammasome activation in macrophages and lung epithelial cells is involved in the development of pneumonia in patients with COVID-19 [32,33,34]. The gene discussed is NLRP3; the disease is susceptibility to pneumonia measurement.